There is little doubt that concurrent CRT has a valuable role in the management of advanced-stage laryngeal carcinoma. The results of both the VA laryngeal trial as well as the RTOG 91-11 trial have given us great insight into the utility of CRT in the management of this disease.1,2 Enepekides has thoroughly reviewed the pertinent literature on the use of both partial laryngeal surgery and CRT for advanced-stage laryngeal carcinoma.
Russell B. Smith. Concurrent Chemoradiation as a Treatment Option for Advanced-Stage Laryngeal Cancers. Arch Otolaryngol Head Neck Surg. 2005;131(9):820. doi:10.1001/archotol.131.9.820